Peptide Library

FDA-approved

Bones & muscles

Palopegteriparatide

Evidence

FDA approved

Class

Long-acting parathyroid hormone prodrug

/

Palopegteriparatide

KEY TAKEAWAY

Palopegteriparatide is teriparatide attached to a carrier that releases it slowly over a day. It is sold as Yorvipath. The FDA approved palopegteriparatide (Yorvipath) in August 2024 for adults with hypoparathyroidism.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Long-acting parathyroid hormone prodrug

Approved for

Hypoparathyroidism in adults

Key fact

The FDA approved palopegteriparatide (Yorvipath) in August 2024 for adults with hypoparathyroidism.

Route

Daily subcutaneous injection

Evidence strength

FDA approved

What it is

What it is

Palopegteriparatide is teriparatide attached to a carrier that releases it slowly over a day. It is sold as Yorvipath.

How it works

How it works

It replaces the parathyroid hormone that people with hypoparathyroidism cannot make, which raises blood calcium.

Regulatory status

Regulatory status

The FDA approved palopegteriparatide (Yorvipath) in August 2024 for adults with hypoparathyroidism.

What it is used for

What it is used for

Hypoparathyroidism in adults.

Side effects and risks

Side effects and risks

Injection-site reactions, high or low blood calcium and headache are reported.

Citations

Citations

U.S. FDA prescribing information for Palopegteriparatide. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo